Help Lines 954-785-1121
 


You are not logged in. Upgrade Here
 <<<Previous Mid Day Report     Next Mid Day Report >>> 
 <<<Previous After Market Report Next After Market Report >>> 
You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Tuesday, October 22, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

 MIDDAY BREAKOUTS REPORT - MONDAY, OCTOBER 16TH, 2023
Previous Mid Day Report Next Mid Day Report >>>

DOW 33993.6 323.31 (0.96%) | NASDAQ 13536.31 129.07 (0.96%) | S&P 500 4370.64 42.86 (0.99%)
Time of Screening : 10/16/2023 12:32:38 PM         Report Released : 10/16/2023 12:52:52 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 65% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page


NONE OF OUR FEATURED STOCKS MET TODAY'S SCREENING CRITERIA FOR VOLUME AND PRICE ACTION.


Symbol - Exchange - Industry Group
Company Name
Last Chg Day
High
52 WK Hi % From Hi Volume
% DAV
DAV
BCML - NASDAQ - Banks-West/Southwest
Baycom Corp
$19.75 +0.04
0.20%
$20.08 $21.07 -6.26% 94,114
376.46%
25,000
Most Recent Note for BCML - 10/16/2023 12:33:06 PM
Earnings increases in the 2 most recent quarterly comparisons through Jun '23 were above the +25% minimum guideline (C criteria). Prior quarters showed sub par earnings and its annual earnings (A criteria) history has been up and down.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CLS - NYSE - Elec-Contract Mfg
Celestica Inc
$26.80 +0.89
3.42%
$27.58 $27.36 -2.07% 1,641,234
94.16%
1,743,000
Most Recent Note for CLS - 10/16/2023 12:33:43 PM
Hitting another new 52-week high with today's volume-driven gain, getting more extended from any sound base. Reported earnings +25% on +13% sales revenues for the Jun '23 quarter versus the year ago period, and 6 of the last 7 quarterly comparisons were above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) history has been strong since bottoming in FY '19.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CQP - AMEX - ENERGY - Oil & Gas Refining & Marketing
Cheniere Energy Partners
$54.33 -0.52
-0.94%
$54.80 $62.08 -12.49% 293,276
127.51%
230,000
Most Recent Note for CQP - 10/16/2023 12:34:52 PM
This MLP has a lackluster annual earnings (A criteria) history and is not a match with the fundamental guidelines of the fact-based investment system. Mar and Jun '23 quarters showed waning sales revenues.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
GHM - AMEX - MANUFACTURING - Metal Fabrication
Graham Corp
$16.32 +0.07
0.43%
$17.00 $17.95 -9.08% 39,043
100.11%
39,000
Most Recent Note for GHM - 10/16/2023 12:36:55 PM
Recently found prompt support near its 50 DMA line ($16.25) and near the prior high. Gapped up on 8/07/23 breaking out of a 5-month base. Quarterly comparisons through Jun '23 have shown great sales revenues and earnings improvement over the year-ago periods. Annual earnings history (A criteria) has been subpar.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
GNTX - NASDAQ - AUTOMOTIVE - Auto Parts
Gentex Corp
$31.31 +0.27
0.87%
$31.54 $34.33 -8.80% 904,971
65.06%
1,391,000
Most Recent Note for GNTX - 10/16/2023 12:37:11 PM
Reported earnings +52% on +26% sales revenues for the Jun '23 quarter versus the year-ago period. Prior quarterly earnings increases have not been a match with the fact-based investment system's fundamental guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
HUBB - NYSE - Electrical-Power/Equipmt
Hubbell Inc
$304.00 +9.21
3.12%
$308.06 $340.06 -10.61% 361,926
87.42%
414,000
Most Recent Note for HUBB - 10/16/2023 12:38:02 PM
Finding prompt support after undercutting the Aug '23 low but its 50 DMA line ($313) acted as resistance when rebounding. It was dropped from the Featured Stocks list on 9/21/23. Fundamentals remain strong.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
HUM - NYSE - HEALTH SERVICES - Health Care Plans
Humana Inc
$521.92 +15.95
3.15%
$525.60 $571.30 -8.64% 668,601
70.38%
950,000
Most Recent Note for HUM - 10/16/2023 12:39:24 PM
Rebounding toward its all-time high making progress above its 50 and 200 DMA lines. Reported Jun '23 quarterly earnings +2% on +13% sales revenues versus the year ago period. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system. Annual earnings (A criteria) history has been strong.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
JPM - NYSE - BANKING - Money Center Banks
J P Morgan Chase & Co
$147.33 -0.67
-0.45%
$149.52 $159.38 -7.56% 6,017,169
69.51%
8,656,000
Most Recent Note for JPM - 10/16/2023 12:40:47 PM
Gapped up on the prior session rebounding above its 50 DMA line ($147.61) with a big volume-driven gain when noted with caution in the mid-day report - "Faces resistance due to overhead supply up to the $159 level. Reported earnings +58% on +34% sales revenues for the Jun '23 quarter versus the year-ago period, its 2nd strong quarterly comparison. Prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system's fundamental guidelines. Went through a deep consolidation since noted with caution in the 10/13/21 mid-day report."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
KTOS - NASDAQ - DIVERSIFIED SERVICES - Technical Services
Kratos Def & Sec Sol Inc
$17.01 +0.06
0.35%
$17.34 $17.73 -4.06% 717,868
74.93%
958,000
Most Recent Note for KTOS - 10/16/2023 12:41:32 PM
Consolidating following noted volume-driven gains, rebounding above its 50 DMA line ($15.47) and hitting a new 52-week high. Noted in prior mid-day reports - "Reported Jun '23 quarterly earnings +29% on +15% sales revenues versus the year-ago period, its 2nd strong quarter. Prior quarterly earnings increases were below the +25% minimum guideline (C criteria)."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
LAKE - NASDAQ - HEALTH SERVICES - Medical Appliances & Equipment
Lakeland Industries Inc
$15.00 +0.30
2.04%
$15.15 $16.07 -6.66% 40,678
203.39%
20,000
Most Recent Note for LAKE - 10/16/2023 12:42:10 PM
Still perched within striking distance of its 52-week high, consolidating in an orderly fashion above its 50 DMA line ($14.81). Reported great earnings increases in the 2 latest quarterly comparisons through Jul '23. Prior quarterly comparisons showed subpar increases versus the year ago periods. Annual earnings growth (A criteria) has been erratic.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
LECO - NASDAQ - MANUFACTURING - Machine Tools & Accessories
Lincoln Electric Hldgs
$184.02 +0.71
0.38%
$186.95 $210.86 -12.73% 270,810
102.97%
263,000
Most Recent Note for LECO - 10/16/2023 12:43:50 PM
Consolidating near its 50 DMA line ($184.79) but it faces near-term resistance due to overhead supply up to the $210 level. Quarterly comparisons through Jun '23 have been below the +25% minimum earnings guideline (C criteria). The downward turn in FY '19 and '20 earnings was noted as a flaw concerning the annual earnings history (A criteria).
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
LULU - NASDAQ - MANUFACTURING - Textile Manufacturing
Lululemon Athletica
$416.58 +38.89
10.30%
$417.47 $410.50 1.48% 6,743,201
527.64%
1,278,000
Most Recent Note for LULU - 10/16/2023 12:45:00 PM
Gapped up today hitting a new 52-week high with a considerable volume-driven gain. Its 200 DMA line acted as support. Reported Jul '23 quarterly earnings +22% on +18% sales revenues versus the year-ago period. Noted with caution in prior mid-day reports - "Faces resistance due to overhead supply up to the $485 level. Three of the 4 latest quarterly comparisons were above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '21."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
NATR - NASDAQ - DRUGS - Drug Related Products
Natures Sunshine Prod
$17.05 +0.75
4.57%
$17.14 $17.25 -1.19% 51,798
78.48%
66,000
Most Recent Note for NATR - 10/16/2023 12:46:31 PM
Built an orderly base and challenging its 52-week high with today's big gain after finding support above its 50 DMA line ($16.20). Prior mid-day reports cautioned members - "Erratic quarterly and annual earnings history (C and A criteria) leaves fundamental concerns. Faces some resistance due to overhead supply up to the $19 level."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
NVO - NYSE - DRUGS - Drug Manufacturers - Other
Novo Nordisk A/S Adr
$100.40 -1.75
-1.71%
$101.47 $104.00 -3.47% 3,536,714
72.55%
4,875,000
Most Recent Note for NVO - 10/16/2023 12:47:06 PM
This Denmark-based Medical - Ethical Drugs firm is pulling back today after hitting new all-time highs with 4 consecutive volume-driven gains. Found support after briefly undercutting its 50 DMA line when noted with caution in the 10/03/23 mid-day report - "Shares split 2-1 on 9/20/23. Reported Jun '23 quarterly earnings +53% on +37% sales revenues versus the year-ago period, its 2nd strong quarter. Fundamental concerns remain. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria)."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
RACE - NYSE - Auto Manufacturers
Ferrari NV
$314.85 +2.83
0.91%
$317.09 $329.88 -4.56% 226,994
84.38%
269,000
Most Recent Note for RACE - 10/16/2023 12:48:04 PM
Faces resistance due to overhead supply up to the $329 level. Rebounded above its 50 DMA line ($304.79) last week after finding recent support above its 200 DMA line. Reported earnings +40% on +19% sales revenues for the Jun '23 quarter versus the year ago period. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria) leaving concerns, fundamentally. Since completing its $52 IPO in Oct '15 its annual earnings (A criteria) history was strong until a downturn in FY '20.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
TEAM - NASDAQ - Comp Sftwr-Spec Enterprs
Atlassian Corp Plc
$195.95 +7.64
4.05%
$199.50 $215.77 -9.19% 872,459
65.65%
1,329,000
Most Recent Note for TEAM - 10/16/2023 12:48:53 PM
Consolidating near its 50 DMA line ($197). Reported improved results for the Mar and Jun '23 quarters versus the year-ago periods but fundamental concerns remain. Went through a deep consolidation since 3/03/21 when it was dropped from the Featured Stocks list.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
TTD - NASDAQ - Comml Svcs-Advertising
The Trade Desk Inc Cl A
$80.30 +0.06
0.07%
$80.42 $91.85 -12.57% 2,253,376
66.16%
3,406,000
Most Recent Note for TTD - 10/16/2023 12:50:58 PM
Testing support near its 50 DMA line ($79.28) and it faces resistance due to overhead supply up to the $114 level. Fundamental concerns remain. Reported Jun '23 quarterly earnings +40% on +23% sales revenues versus the year-ago period. Two of the 4 latest quarterly comparisons showed earnings increases below the +25% minimum earnings guideline (C criteria) versus the year ago period. Went through a deep consolidation since dropped from the Featured Stocks list on 1/04/22.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
UNH - NYSE - HEALTH SERVICES - Health Care Plans
Unitedhealth Group Inc
$540.65 +1.25
0.23%
$546.78 $558.10 -3.13% 1,866,745
68.71%
2,717,000
Most Recent Note for UNH - 10/16/2023 12:51:36 PM
Gapped up on the prior session rebounding near its all-time high. Fundamental concerns remain. Quarterly comparisons through Jun '23 were not strong and steady above the +25% minimum earnings guideline (C criteria). Annual earnings growth has been strong and steady.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
VRTX - NASDAQ - Medical-Biomed/Biotech
Vertex Pharmaceuticals
$371.84 +0.84
0.23%
$374.02 $373.92 -0.56% 996,931
114.07%
874,000
Most Recent Note for VRTX - 10/16/2023 12:52:46 PM
Faces no resistance due to overhead supply as it is hitting a new all-time high with today's 5th consecutive volume-driven gain. Reported Jun '23 quarterly earnings +8% on +14% sales revenues versus the year-ago period. Three of the 4 latest quarterly comparisons were well below the +25% minimum earnings guideline (C criteria).
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  

THESE ARE NOT BUY RECOMMENDATIONS!  Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time.  Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

 We appreciate any feedback members may wish to send via the inquiry form here.

Kenneth J. Gruneisen founded Gruneisen Growth Corp. (2003), which prior to May 11, 2015, operated CANSLIM.net and CANSLIM.com both under license from Data Analysis Inc. / Investor's Business Daily. Kenneth has passed the CAN SLIM® Master's Exam. Gruneisen Growth Corp. now continues over two decades of fact based market analysis via FactBasedInvesting.com.

Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties

Privacy Policy | Terms of Use | Contact Us